Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma
Year: 2009
Type: article
Study design: Clinical Trial
Source: Chemotherapy
DOI: 10.1159/000219435
Authors: Patrick A. Ott, Jason L. Chang, Ruth Oratz, Amanda Jones, Kathleen Farrell, Franco Muggia, Anna C. Pavlick
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W1973752108
